Connect with us
– Glenmark Kicks Off Nation-wide Initiative at the Iconic Gateway of India to Promote Home Blood Pressure Monitoring Starting at Age 18. Mumbai, September 27, 2024:...
‐ Glenmark is the first company in India to launch Thiazolidinedione Lobeglitazone (0.5 mg). ‐ This anti-diabetic medication will be marketed under brand name LOBG....
Mumbai, September 28, 2022: Glenmark Pharmaceuticals Limited (Glenmark), an innovation-driven, global pharmaceutical company, in partnership with Association of Physicians of India (API), Indian Medical Association (IMA) – Mumbai West...
Glenmark becomes the first company in the world to launch Ryaltris®-AZ as a novel fixed dose combination of Mometasone furoate 50 mcg + Azelastine 140 mcg....
